Cirevetmab
Modify Date: 2024-04-07 00:50:57
Cirevetmab structure
|
Common Name | Cirevetmab | ||
|---|---|---|---|---|
| CAS Number | 2473240-98-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of CirevetmabCirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, anti-[Canis lupus familiaris TGFB1], caninized monoclonal antibody. Cirevetmab is an immunomodulator[1]. |
| Name | Cirevetmab |
|---|
| Description | Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, anti-[Canis lupus familiaris TGFB1], caninized monoclonal antibody. Cirevetmab is an immunomodulator[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |